Outpatient Management of CAR-T and Teclistamab for Patients with Lymphoma and Multiple Myeloma

被引：7
|
作者：
Bansal, Radhika [1 ]
Paludo, Jonas [2 ]
Corraes, Andre [2 ]
Spychalla, Megan [2 ]
Haugen, Kelsey [2 ]
Khurana, Arushi [2 ]
Hampel, Paul J. [2 ]
Durani, Urshila [3 ]
Dingli, David [2 ]
Hayman, Suzanne R. [2 ]
Kapoor, Prashant [2 ]
Wang, Yucai [3 ]
Binder, Moritz [2 ]
Kenderian, Saad S. [3 ]
Kourelis, Taxiarchis [3 ]
Kumar, Shaji Kunnathu [3 ]
Warsame, Rahma M. [4 ]
Bennani, N. Nora [2 ]
Gertz, Morie A. [5 ]
Johnston, Patrick B. [3 ]
Ansell, Stephen M. [3 ]
Lin, Yi [1 ]
机构：
[1] Mayo Clin, Canc Ctr, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
[3] Mayo Clin, Div Hematol, Rochester, MN USA
[4] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN USA
[5] Mayo Clin, Div Hematol, Dept Med, Rochester, MN USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187186
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Outpatient practice utilization for CAR-T and T cell engager in patients with lymphoma and multiple myeloma
    Bansal, Radhika
    Paludo, Jonas
    Corraes, Andre De Menezes Silva
    Megan, Spychalla
    Khurana, Arushi
    Hampel, Paul Joseph
    Durani, Urshila
    Dingli, David
    Hayman, Suzanne R.
    Kapoor, Prashant
    Wang, Yucai
    Binder, Moritz
    Kourelis, Taxiarchis
    Kumar, Shaji
    Warsame, Rahma M.
    Bennani, Nabila Nora
    Gertz, Morie A.
    Johnston, Patrick B.
    Ansell, Stephen M.
    Lin, Yi
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Outpatient Practice Pattern for Recently Approved CAR-T in Patients with Lymphoma and Multiple Myeloma
    Bansal, Radhika
    Paludo, Jonas
    Hathcock, Matthew A.
    Spychalla, Megan T.
    Khurana, Arushi
    Hampel, Paul J.
    Durani, Urshila
    Alkhateeb, Hassan B.
    Dingli, David
    Hayman, Suzanne R.
    Kapoor, Prashant
    Wang, Yucai
    Kenderian, Saad S.
    Binder, Moritz
    Kourelis, Taxiarchis
    Kumar, Shaji K.
    Shah, Mithun, V
    Warsame, Rahma M.
    Bennani, N. Nora
    Gertz, Morie A.
    Johnston, Patrick B.
    Ansell, Stephen M.
    Siddiqui, Mustaqeem A.
    Lin, Yi
    BLOOD, 2022, 140 : 2399 - 2401
  • [3] Teclistamab Success in CAR-T Refractory Multiple Myeloma: A Case Presentation
    Fleischmann, Bastian
    Jain, Sayli
    Bello, Adriana
    Zubair, Rabi
    Hempel, Dirk
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S536 - S536
  • [4] Incidence of acute kidney injury in relapsed and refractory multiple myeloma treated with teclistamab versus CAR-T cells
    Charkviani, Mariam
    Brochero, Maria Jose Vargas
    Mohan, Arjunmohan
    Vaughan, Lisa E.
    Sandahl, Tyler B.
    Corraes, Andre De Menezes Silva
    Lin, Yi
    Leung, Nelson
    Herrmann, Sandra M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025,
  • [5] Total Car-T Cost of Care Beyond the Price of Car-T Cell Therapy in Patients with Multiple Myeloma
    Jagannath, Sundar
    Joseph, Nedra
    Crivera, Concetta
    Jackson, Carolyn C.
    Valluri, Satish
    Cost, Patricia
    Phelps, Hilary
    Slowik, Rafal
    Klein, Timothy
    Yu, Xueting
    Smolen, Lee
    Cohen, Adam D.
    BLOOD, 2021, 138
  • [6] STANDARDIZING CARE OF MULTIPLE MYELOMA PATIENTS RECEIVING INVESTIGATIONAL CAR-T
    You, Ashlee
    Catamero, Donna
    ONCOLOGY NURSING FORUM, 2024, 51 (02)
  • [7] CAR-T Therapy in Relapsed Refractory Multiple Myeloma
    Ding, Hong
    Wu, Yu
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (27) : 4362 - 4382
  • [8] CAR-T cells in multiple myeloma: current status
    Steiner, Normann
    Gunsilius, Eberhard
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (01) : 43 - 49
  • [9] FDA OKs first CAR-T for multiple myeloma
    Satyanarayana, Megha
    CHEMICAL & ENGINEERING NEWS, 2021, 99 (12) : 13 - 13
  • [10] A new CAR-T cell therapy for multiple myeloma
    Hosen, Naoki
    CANCER SCIENCE, 2022, 113 : 644 - 644
12345